Signs of inflammatory bowel disease (IBD ... the long data collection period involved changes in treatment models for IBD and C difficile infection, which may have influenced the results.
Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...
Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...
Investigators at Pennsylvania State University have described a novel approach to combat Clostridioides difficile infection ...
A new UConn study reveals that tagatose, a plant-based sugar alternative, shows promise in mitigating Clostridioides difficile (C. difficile) infection, particularly those resistant to antibiotics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results